Genetic Characterization of Molecular Targets in Korean Patients with Gastrointestinal Stromal Tumors.

Our study confirmed the advantage of using targeted NGS with a cancer gene panel to efficiently identify mutations associated with GISTs. These findings may provide a molecular genetic basis for developing new drugs targeting these gene mutations for GIST therapy.